Global Oral Polio Vaccines (OPV) Market Research Report 2021-2027

  • receipt Report ID : 223056
  • calendar_today Published On: Jul, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare

The Oral Polio Vaccines (OPV) market report offers in in-dept analysis on the global market size, market share, market growth, sales analysis, regional analysis, market developments, opportunities, and forecasts that will help you in strategizing and expanding your business.

As per the most recent analysis conducted by our research team, the global Oral Polio Vaccines (OPV) market size is projected to reach US$ XX million by 2027 from US $ XX million in 2020 at a CAGR of XX% during 2021-2027.

The report included detailed analysis on the Oral Polio Vaccines (OPV) production capacity, its market share by manufacturers, growth rate, regional production capacity, ex-factory rate, and other important data points. The report also covers Oral Polio Vaccines (OPV) consumption globally as well as thorough bifurcation into regional and country wise consumption.

The research team goes an additional mile to comprehensively cover other important aspects on Oral Polio Vaccines (OPV) market such as the market dynamics, market segmentation, competition, growth prospects, and growth strategies. The buyers of this report will have access to exclusive data that covers market share by applications, manufacturers, regions, and countries. The document also covers market size by type, market competition by manufacturers, sales volume, growth rate, revenue, price and gross margins. Moreover, the authors of this report provide authentic calculations and estimations for global revenue and volume by type segments for Oral Polio Vaccines (OPV) market covering the period 2016-2027.

This report includes the following key manufacturers. We can also add other companies of your choice and customize the report as per your requirements.

  • Sanofi
  • GSK
  • Bibcol
  • Serum Institute
  • Tiantan Biological
  • Panacea Biotec Ltd
  • Bio-Med
  • Halfkin Bio-Pharmaceuticals

Market Segment by Type

  • Trivalent OPV
  • Bivalent OPV

Market Segment by Application

  • Public
  • Private

Market Segment by Regions and Countries

  • North America (United States, Canada, Mexico)
  • Asia-Pacific (China, India, Japan, Taiwan, South Korea, Australia, Indonesia, Singapore, Malaysia, Rest of Asia-Pacific)
  • Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)
  • Central & South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Turkey, Rest of Middle East & Africa)

The study objectives of this report are:

  • Overview of the Oral Polio Vaccines (OPV) market
  • Analysis on key market segments
  • Key manufacturer analysis based on production, sales, and revenue
  • Oral Polio Vaccines (OPV) market regional and country wise analysis for production and consumption
  • Study the forecast of market in respect to manufacturers, segments, and regions
  • Identify significant trends and factors driving the market growth
  • Analyse the available opportunities in the market by tracing high growth segments
  • Analyse competitive developments like acquisitions, expansions, product launches, agreements, etc.
  • Study the growth strategies of key manufacturers
  • SWOT analysis

In this study, the years considered to estimate the market size of Oral Polio Vaccines (OPV) are as follows:

History Year: 2016-2020

Base Year: 2020

Estimated Year: 2021

Forecast Year 2021 to 2027

Available Customizations

Market Research Place offers customizations according to the client's specific needs. The report can be customized on the basis of manufacturers, regions, applications, etc. Contact us to know more about the customization options.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Report Overview

1.1 Research Scope

1.2 Market Segment by Type

1.2.1 Global Oral Polio Vaccines (OPV) Market Size Growth Rate by Type

1.2.2 Trivalent OPV

1.2.3 Bivalent OPV

1.3 Market Segment by Application

1.3.1 Global Oral Polio Vaccines (OPV) Market Share by Application (2016 VS 2021 VS 2027)

1.3.2 Public

1.3.3 Private

1.4 Study Objectives

1.5 Years Considered

2 Market Perspective

2.1 Global Oral Polio Vaccines (OPV) Market Size (2016-2027)

2.1.1 Global Oral Polio Vaccines (OPV) Revenue (2016-2027)

2.1.2 Global Oral Polio Vaccines (OPV) Sales (2016-2027)

2.2 Global Oral Polio Vaccines (OPV) Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027

2.2.1 Global Oral Polio Vaccines (OPV) Sales by Regions (2016-2021)

2.2.2 Global Oral Polio Vaccines (OPV) Revenue by Regions (2016-2021)

2.3 Global Oral Polio Vaccines (OPV) Market Size Forecast by Region

2.3.1 Global Oral Polio Vaccines (OPV) Sales Forecast by Region (2022-2027)

2.3.2 Global Oral Polio Vaccines (OPV) Revenue Forecast by Region (2022-2027)

2.4 Global Top Oral Polio Vaccines (OPV) Regions (Countries) Ranking by Market Size

2.5 Oral Polio Vaccines (OPV) Industry Trends

2.5.1 Oral Polio Vaccines (OPV) Market Trends

2.5.2 Oral Polio Vaccines (OPV) Market Drivers

2.5.3 Oral Polio Vaccines (OPV) Market Challenges

2.5.4 Oral Polio Vaccines (OPV) Market Restraints

3 Competitive Landscape by Manufacturers

3.1 Global Top Oral Polio Vaccines (OPV) Manufacturers by Sales (2016-2021)

3.1.1 Global Oral Polio Vaccines (OPV) Sales by Manufacturers (2016-2021)

3.1.2 Global Oral Polio Vaccines (OPV) Sales Market Share by Manufacturers (2016-2021)

3.1.3 Global 5 and 10 Largest Manufacturers by Oral Polio Vaccines (OPV) Sales in 2020

3.2 Global Top Manufacturers Oral Polio Vaccines (OPV) by Revenue

3.2.1 Global Oral Polio Vaccines (OPV) Revenue by Manufacturers (2016-2021)

3.2.2 Top Oral Polio Vaccines (OPV) Manufacturers Covered: Ranking by Revenue

3.2.3 Global Oral Polio Vaccines (OPV) Revenue Share by Manufacturers (2016-2021)

3.2.4 Global Oral Polio Vaccines (OPV) Market Concentration Ratio (CR5 and HHI)

3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Polio Vaccines (OPV) as of 2020)

3.4 Global Oral Polio Vaccines (OPV) Average Selling Price (ASP) by Manufacturers

3.5 Key Manufacturers Oral Polio Vaccines (OPV) Plants/Factories Distribution and Area Served

3.6 Date of Key Manufacturers Enter into Oral Polio Vaccines (OPV) Market

3.7 Key Manufacturers Oral Polio Vaccines (OPV) Product Offered

3.8 Mergers & Acquisitions, Expansion Plans

4 Global Oral Polio Vaccines (OPV) Market Size by Type

4.1 Global Oral Polio Vaccines (OPV) Historic Market Review by Type (2016-2021)

4.1.1 Global Oral Polio Vaccines (OPV) Sales Market Share by Type (2016-2021)

4.1.2 Global Oral Polio Vaccines (OPV) Revenue Market Share by Type (2016-2021)

4.1.3 Oral Polio Vaccines (OPV) Price by Type (2016-2021)

4.2 Global Oral Polio Vaccines (OPV) Market Estimates and Forecasts by Type (2022-2027)

4.2.1 Global Oral Polio Vaccines (OPV) Sales Forecast by Type (2022-2027)

4.2.2 Global Oral Polio Vaccines (OPV) Revenue Forecast by Type (2022-2027)

4.2.3 Oral Polio Vaccines (OPV) Price Forecast by Type (2022-2027)

5 Global Oral Polio Vaccines (OPV) Market Size by Application

5.1 Global Oral Polio Vaccines (OPV) Historic Market Review by Application (2016-2021)

5.1.1 Global Oral Polio Vaccines (OPV) Sales Market Share by Application (2016-2021)

5.1.2 Global Oral Polio Vaccines (OPV) Revenue Market Share by Application (2016-2021)

5.1.3 Oral Polio Vaccines (OPV) Price by Application (2016-2021)

5.2 Global Oral Polio Vaccines (OPV) Market Estimates and Forecasts by Application (2022-2027)

5.2.1 Global Oral Polio Vaccines (OPV) Sales Forecast by Application (2022-2027)

5.2.2 Global Oral Polio Vaccines (OPV) Revenue Forecast by Application (2022-2027)

5.2.3 Oral Polio Vaccines (OPV) Price Forecast by Application (2022-2027)

6 North America

6.1 North America Oral Polio Vaccines (OPV) Sales Breakdown by Company

6.1.1 North America Oral Polio Vaccines (OPV) Sales by Company (2016-2027)

6.1.2 North America Oral Polio Vaccines (OPV) Revenue by Company (2016-2027)

6.2 North America Oral Polio Vaccines (OPV) Market Size by Type (2016-2027)

6.2.1 North America Oral Polio Vaccines (OPV) Sales by Type (2016-2027)

6.2.2 North America Oral Polio Vaccines (OPV) Revenue by Type (2016-2027)

6.3 North America Oral Polio Vaccines (OPV) Market Size by Application (2016-2027)

6.3.1 North America Oral Polio Vaccines (OPV) Sales by Application (2016-2027)

6.3.2 North America Oral Polio Vaccines (OPV) Revenue by Application (2016-2027)

6.4 North America Oral Polio Vaccines (OPV) Market Size by Country

6.4.1 North America Oral Polio Vaccines (OPV) Sales by Country (2016-2027)

6.4.2 North America Oral Polio Vaccines (OPV) Revenue by Country (2016-2027)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Oral Polio Vaccines (OPV) Sales Breakdown by Company

7.1.1 Europe Oral Polio Vaccines (OPV) Sales by Company (2016-2027)

7.1.2 Europe Oral Polio Vaccines (OPV) Revenue by Company (2016-2027)

7.2 Europe Oral Polio Vaccines (OPV) Market Size by Type (2016-2027)

7.2.1 Europe Oral Polio Vaccines (OPV) Sales by Type (2016-2027)

7.2.2 Europe Oral Polio Vaccines (OPV) Revenue by Type (2016-2027)

7.3 Europe Oral Polio Vaccines (OPV) Market Size by Application (2016-2027)

7.3.1 Europe Oral Polio Vaccines (OPV) Sales by Application (2016-2027)

7.3.2 Europe Oral Polio Vaccines (OPV) Revenue by Application (2016-2027)

7.4 Europe Oral Polio Vaccines (OPV) Market Size by Country

7.4.1 Europe Oral Polio Vaccines (OPV) Sales by Country (2016-2027)

7.4.2 Europe Oral Polio Vaccines (OPV) Revenue by Country (2016-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

8 Asia Pacific

8.1 Asia Pacific Oral Polio Vaccines (OPV) Sales Breakdown by Company

8.1.1 Asia Pacific Oral Polio Vaccines (OPV) Sales by Company (2016-2027)

8.1.2 Asia Pacific Oral Polio Vaccines (OPV) Revenue by Company (2016-2027)

8.2 Asia Pacific Oral Polio Vaccines (OPV) Market Size by Type (2016-2027)

8.2.1 Asia Pacific Oral Polio Vaccines (OPV) Sales by Type (2016-2027)

8.2.2 Asia Pacific Oral Polio Vaccines (OPV) Revenue by Type (2016-2027)

8.3 Asia Pacific Oral Polio Vaccines (OPV) Market Size by Application (2016-2027)

8.3.1 Asia Pacific Oral Polio Vaccines (OPV) Sales by Application (2016-2027)

8.3.2 Asia Pacific Oral Polio Vaccines (OPV) Revenue by Application (2016-2027)

8.4 Asia Pacific Oral Polio Vaccines (OPV) Market Size by Regions

8.4.1 Asia Pacific Oral Polio Vaccines (OPV) Sales by Regions

8.4.2 Asia Pacific Oral Polio Vaccines (OPV) Revenue by Regions

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 India

8.4.7 Australia

8.4.8 Taiwan

8.4.9 Indonesia

8.4.10 Thailand

8.4.11 Malaysia

8.4.12 Philippines

8.4.13 Vietnam

9 Latin America

9.1 Latin America Oral Polio Vaccines (OPV) Sales Breakdown by Company

9.1.1 Latin America Oral Polio Vaccines (OPV) Sales by Company (2016-2027)

9.1.2 Latin America Oral Polio Vaccines (OPV) Revenue by Company (2016-2027)

9.2 Latin America Oral Polio Vaccines (OPV) Market Size by Type (2016-2027)

9.2.1 Latin America Oral Polio Vaccines (OPV) Sales by Type (2016-2027)

9.2.2 Latin America Oral Polio Vaccines (OPV) Revenue by Type (2016-2027)

9.3 Latin America Oral Polio Vaccines (OPV) Market Size by Application (2016-2027)

9.3.1 Latin America Oral Polio Vaccines (OPV) Sales by Application (2016-2027)

9.3.2 Latin America Oral Polio Vaccines (OPV) Revenue by Application (2016-2027)

9.4 Latin America Oral Polio Vaccines (OPV) Market Size by Country

9.4.1 Latin America Oral Polio Vaccines (OPV) Sales by Country (2016-2027)

9.4.2 Latin America Oral Polio Vaccines (OPV) Revenue by Country (2016-2027)

9.4.3 Mexico

9.4.4 Brazil

9.4.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Oral Polio Vaccines (OPV) Sales Breakdown by Company

10.1.1 Middle East and Africa Oral Polio Vaccines (OPV) Sales by Company (2016-2027)

10.1.2 Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Company (2016-2027)

10.2 Middle East and Africa Oral Polio Vaccines (OPV) Market Size by Type (2016-2027)

10.2.1 Middle East and Africa Oral Polio Vaccines (OPV) Sales by Type (2016-2027)

10.2.2 Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Type (2016-2027)

10.3 Middle East and Africa Oral Polio Vaccines (OPV) Market Size by Application (2016-2027)

10.3.1 Middle East and Africa Oral Polio Vaccines (OPV) Sales by Application (2016-2027)

10.3.2 Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Application (2016-2027)

10.4 Middle East and Africa Oral Polio Vaccines (OPV) Market Size by Country

10.4.1 Middle East and Africa Oral Polio Vaccines (OPV) Sales by Country (2016-2027)

10.4.2 Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Country (2016-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 U.A.E

11 Company Profiles

11.1 Sanofi

11.1.1 Sanofi Corporation Information

11.1.2 Sanofi Overview

11.1.3 Sanofi Oral Polio Vaccines (OPV) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.1.4 Sanofi Oral Polio Vaccines (OPV) Products and Services

11.1.5 Sanofi Oral Polio Vaccines (OPV) SWOT Analysis

11.1.6 Sanofi Recent Developments

11.2 GSK

11.2.1 GSK Corporation Information

11.2.2 GSK Overview

11.2.3 GSK Oral Polio Vaccines (OPV) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.2.4 GSK Oral Polio Vaccines (OPV) Products and Services

11.2.5 GSK Oral Polio Vaccines (OPV) SWOT Analysis

11.2.6 GSK Recent Developments

11.3 Bibcol

11.3.1 Bibcol Corporation Information

11.3.2 Bibcol Overview

11.3.3 Bibcol Oral Polio Vaccines (OPV) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.3.4 Bibcol Oral Polio Vaccines (OPV) Products and Services

11.3.5 Bibcol Oral Polio Vaccines (OPV) SWOT Analysis

11.3.6 Bibcol Recent Developments

11.4 Serum Institute

11.4.1 Serum Institute Corporation Information

11.4.2 Serum Institute Overview

11.4.3 Serum Institute Oral Polio Vaccines (OPV) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.4.4 Serum Institute Oral Polio Vaccines (OPV) Products and Services

11.4.5 Serum Institute Oral Polio Vaccines (OPV) SWOT Analysis

11.4.6 Serum Institute Recent Developments

11.5 Tiantan Biological

11.5.1 Tiantan Biological Corporation Information

11.5.2 Tiantan Biological Overview

11.5.3 Tiantan Biological Oral Polio Vaccines (OPV) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.5.4 Tiantan Biological Oral Polio Vaccines (OPV) Products and Services

11.5.5 Tiantan Biological Oral Polio Vaccines (OPV) SWOT Analysis

11.5.6 Tiantan Biological Recent Developments

11.6 Panacea Biotec Ltd

11.6.1 Panacea Biotec Ltd Corporation Information

11.6.2 Panacea Biotec Ltd Overview

11.6.3 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.6.4 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Products and Services

11.6.5 Panacea Biotec Ltd Oral Polio Vaccines (OPV) SWOT Analysis

11.6.6 Panacea Biotec Ltd Recent Developments

11.7 Bio-Med

11.7.1 Bio-Med Corporation Information

11.7.2 Bio-Med Overview

11.7.3 Bio-Med Oral Polio Vaccines (OPV) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.7.4 Bio-Med Oral Polio Vaccines (OPV) Products and Services

11.7.5 Bio-Med Oral Polio Vaccines (OPV) SWOT Analysis

11.7.6 Bio-Med Recent Developments

11.8 Halfkin Bio-Pharmaceuticals

11.8.1 Halfkin Bio-Pharmaceuticals Corporation Information

11.8.2 Halfkin Bio-Pharmaceuticals Overview

11.8.3 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.8.4 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Products and Services

11.8.5 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) SWOT Analysis

11.8.6 Halfkin Bio-Pharmaceuticals Recent Developments

12 Value Chain and Sales Channels Analysis

12.1 Oral Polio Vaccines (OPV) Value Chain Analysis

12.2 Oral Polio Vaccines (OPV) Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Oral Polio Vaccines (OPV) Production Mode & Process

12.4 Oral Polio Vaccines (OPV) Sales and Marketing

12.4.1 Oral Polio Vaccines (OPV) Sales Channels

12.4.2 Oral Polio Vaccines (OPV) Distributors

12.5 Oral Polio Vaccines (OPV) Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

List of Tables

Table 1. Global Oral Polio Vaccines (OPV) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)

Table 2. Major Manufacturers of Trivalent OPV

Table 3. Major Manufacturers of Bivalent OPV

Table 4. Global Oral Polio Vaccines (OPV) Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)

Table 5. Global Market Oral Polio Vaccines (OPV) Market Size (US$ Million) by Region: 2016 VS 2021 VS 2027

Table 6. Global Oral Polio Vaccines (OPV) Sales by Region (2016-2021) & (M Doses)

Table 7. Global Oral Polio Vaccines (OPV) Sales Market Share by Region (2016-2021)

Table 8. Global Oral Polio Vaccines (OPV) Revenue by Region (2016-2021) & (US$ Million)

Table 9. Global Oral Polio Vaccines (OPV) Revenue Market Share by Region (2016-2021)

Table 10. Global Oral Polio Vaccines (OPV) Sales Forecast by Region (2022-2027) & (M Doses)

Table 11. Global Oral Polio Vaccines (OPV) Sales Market Share Forecast by Region (2022-2027)

Table 12. Global Oral Polio Vaccines (OPV) Revenue Forecast by Region (2022-2027) & (US$ Million)

Table 13. Global Oral Polio Vaccines (OPV) Revenue Market Share Forecast by Region (2022-2027)

Table 14. Top Oral Polio Vaccines (OPV) Regions (Countries) Ranking by Market Size (US$ Million) in 2020

Table 15. Oral Polio Vaccines (OPV) Market Trends

Table 16. Oral Polio Vaccines (OPV) Market Drivers

Table 17. Oral Polio Vaccines (OPV) Market Challenges

Table 18. Oral Polio Vaccines (OPV) Market Restraints

Table 19. Global Oral Polio Vaccines (OPV) Sales by Manufacturers (2016-2021) & (M Doses)

Table 20. Global Oral Polio Vaccines (OPV) Sales Share by Manufacturers (2016-2021)

Table 21. Global Oral Polio Vaccines (OPV) Revenue by Manufacturers (2016-2021) & (US$ Million)

Table 22. Ranking of Global Top Oral Polio Vaccines (OPV) Manufacturers by Revenue (US$ Million) in 2020

Table 23. Oral Polio Vaccines (OPV) Revenue Share by Manufacturers (2016-2021)

Table 24. Global Oral Polio Vaccines (OPV) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Polio Vaccines (OPV) as of 2020)

Table 26. Key Manufacturers Oral Polio Vaccines (OPV) Average Selling Price (ASP) & (2016-2021) & (USD/Doses)

Table 27. Key Manufacturers Oral Polio Vaccines (OPV) Plants/Factories Distribution

Table 28. Key Manufacturers Oral Polio Vaccines (OPV) Area Served

Table 29. Date of Key Manufacturers Enter into Oral Polio Vaccines (OPV) Market

Table 30. Key Manufacturers Oral Polio Vaccines (OPV) Product Type

Table 31. Mergers & Acquisitions, Expansion Plans

Table 32. Global Oral Polio Vaccines (OPV) Sales (M Doses) by Type (2016-2021)

Table 33. Global Oral Polio Vaccines (OPV) Sales Share by Type (2016-2021)

Table 34. Global Oral Polio Vaccines (OPV) Revenue (US$ Million) Market Share by Type (2016-2021)

Table 35. Global Oral Polio Vaccines (OPV) Price (M Doses) by Type (2016-2021)

Table 36. Global Oral Polio Vaccines (OPV) Sales (M Doses) by Type (2022-2027)

Table 37. Global Oral Polio Vaccines (OPV) Sales Share by Type (2022-2027)

Table 38. Global Oral Polio Vaccines (OPV) Revenue (US$ Million) Market Share by Type (2022-2027)

Table 39. Global Oral Polio Vaccines (OPV) Revenue Share by Type (2022-2027)

Table 40. Global Oral Polio Vaccines (OPV) Price (M Doses) by Type (2022-2027)

Table 41. Global Oral Polio Vaccines (OPV) Sales (M Doses) by Application (2016-2021)

Table 42. Global Oral Polio Vaccines (OPV) Sales Share by Application (2016-2021)

Table 43. Global Oral Polio Vaccines (OPV) Revenue (US$ Million) Market Share by Application (2016-2021)

Table 44. Global Oral Polio Vaccines (OPV) Price (M Doses) by Application (2016-2021)

Table 45. Global Oral Polio Vaccines (OPV) Sales (M Doses) by Application (2022-2027)

Table 46. Global Oral Polio Vaccines (OPV) Sales Share by Application (2022-2027)

Table 47. Global Oral Polio Vaccines (OPV) Revenue (US$ Million) Market Share by Application (2022-2027)

Table 48. Global Oral Polio Vaccines (OPV) Revenue Share by Application (2022-2027)

Table 49. Global Oral Polio Vaccines (OPV) Price (M Doses) by Application (2022-2027)

Table 50. North America Oral Polio Vaccines (OPV) Sales by Company (2016-2021) & (M Doses)

Table 51. North America Oral Polio Vaccines (OPV) Sales Market Share by Company (2016-2021)

Table 52. North America Oral Polio Vaccines (OPV) Revenue by Company (2016-2021) & (US$ Million)

Table 53. North America Oral Polio Vaccines (OPV) Revenue Market Share by Company (2016-2021)

Table 54. North America Oral Polio Vaccines (OPV) Sales by Application (2016-2021) & (M Doses)

Table 55. North America Oral Polio Vaccines (OPV) Sales by Application (2022-2027) & (M Doses)

Table 56. North America Oral Polio Vaccines (OPV) Revenue by Application (2016-2021) & (US$ Million)

Table 57. North America Oral Polio Vaccines (OPV) Revenue by Application (2022-2027) & (US$ Million)

Table 58. North America Oral Polio Vaccines (OPV) Sales by Application (2016-2021) & (M Doses)

Table 59. North America Oral Polio Vaccines (OPV) Sales by Application (2022-2027) & (M Doses)

Table 60. North America Oral Polio Vaccines (OPV) Revenue by Application (2016-2021) & (US$ Million)

Table 61. North America Oral Polio Vaccines (OPV) Revenue by Application (2022-2027) & (US$ Million)

Table 62. North America Oral Polio Vaccines (OPV) Sales by Country (2016-2021) & (M Doses)

Table 63. North America Oral Polio Vaccines (OPV) Sales by Country (2022-2027) & (M Doses)

Table 64. North America Oral Polio Vaccines (OPV) Revenue by Country (2016-2021) & (US$ Million)

Table 65. North America Oral Polio Vaccines (OPV) Revenue by Country (2022-2027) & (US$ Million)

Table 66. Europe Oral Polio Vaccines (OPV) Sales by Company (2016-2021) & (M Doses)

Table 67. Europe Oral Polio Vaccines (OPV) Sales Market Share by Company (2016-2021)

Table 68. Europe Oral Polio Vaccines (OPV) Revenue by Company (2016-2021) & (US$ Million)

Table 69. Europe Oral Polio Vaccines (OPV) Revenue Market Share by Company (2016-2021)

Table 70. Europe Oral Polio Vaccines (OPV) Sales by Application (2016-2021) & (M Doses)

Table 71. Europe Oral Polio Vaccines (OPV) Sales by Application (2022-2027) & (M Doses)

Table 72. Europe Oral Polio Vaccines (OPV) Revenue by Application (2016-2021) & (US$ Million)

Table 73. Europe Oral Polio Vaccines (OPV) Revenue by Application (2022-2027) & (US$ Million)

Table 74. Europe Oral Polio Vaccines (OPV) Sales by Application (2016-2021) & (M Doses)

Table 75. Europe Oral Polio Vaccines (OPV) Sales by Application (2022-2027) & (M Doses)

Table 76. Europe Oral Polio Vaccines (OPV) Revenue by Application (2016-2021) & (US$ Million)

Table 77. Europe Oral Polio Vaccines (OPV) Revenue by Application (2022-2027) & (US$ Million)

Table 78. Europe Oral Polio Vaccines (OPV) Sales by Country (2016-2021) & (M Doses)

Table 79. Europe Oral Polio Vaccines (OPV) Sales by Country (2022-2027) & (M Doses)

Table 80. Europe Oral Polio Vaccines (OPV) Revenue by Country (2016-2021) & (US$ Million)

Table 81. Europe Oral Polio Vaccines (OPV) Revenue by Country (2022-2027) & (US$ Million)

Table 82. Asia Pacific Oral Polio Vaccines (OPV) Sales by Company (2016-2021) & (M Doses)

Table 83. Asia Pacific Oral Polio Vaccines (OPV) Sales Market Share by Company (2016-2021)

Table 84. Asia Pacific Oral Polio Vaccines (OPV) Revenue by Company (2016-2021) & (US$ Million)

Table 85. Asia Pacific Oral Polio Vaccines (OPV) Revenue Market Share by Company (2016-2021)

Table 86. Asia Pacific Oral Polio Vaccines (OPV) Sales by Application (2016-2021) & (M Doses)

Table 87. Asia Pacific Oral Polio Vaccines (OPV) Sales by Application (2022-2027) & (M Doses)

Table 88. Asia Pacific Oral Polio Vaccines (OPV) Revenue by Application (2016-2021) & (US$ Million)

Table 89. Asia Pacific Oral Polio Vaccines (OPV) Revenue by Application (2022-2027) & (US$ Million)

Table 90. Asia Pacific Oral Polio Vaccines (OPV) Sales by Application (2016-2021) & (M Doses)

Table 91. Asia Pacific Oral Polio Vaccines (OPV) Sales by Application (2022-2027) & (M Doses)

Table 92. Asia Pacific Oral Polio Vaccines (OPV) Revenue by Application (2016-2021) & (US$ Million)

Table 93. Asia Pacific Oral Polio Vaccines (OPV) Revenue by Application (2022-2027) & (US$ Million)

Table 94. Asia Pacific Oral Polio Vaccines (OPV) Sales by Region (2016-2021) & (M Doses)

Table 95. Asia Pacific Oral Polio Vaccines (OPV) Sales by Region (2022-2027) & (M Doses)

Table 96. Asia Pacific Oral Polio Vaccines (OPV) Revenue by Region (2016-2021) & (US$ Million)

Table 97. Asia Pacific Oral Polio Vaccines (OPV) Revenue by Region (2022-2027) & (US$ Million)

Table 98. Latin America Oral Polio Vaccines (OPV) Sales by Company (2016-2021) & (M Doses)

Table 99. Latin America Oral Polio Vaccines (OPV) Sales Market Share by Company (2016-2021)

Table 100. Latin America Oral Polio Vaccines (OPV) Revenue by Company (2016-2021) & (US$ Million)

Table 101. Latin America Oral Polio Vaccines (OPV) Revenue Market Share by Company (2016-2021)

Table 102. Latin America Oral Polio Vaccines (OPV) Sales by Application (2016-2021) & (M Doses)

Table 103. Latin America Oral Polio Vaccines (OPV) Sales by Application (2022-2027) & (M Doses)

Table 104. Latin America Oral Polio Vaccines (OPV) Revenue by Application (2016-2021) & (US$ Million)

Table 105. Latin America Oral Polio Vaccines (OPV) Revenue by Application (2022-2027) & (US$ Million)

Table 106. Latin America Oral Polio Vaccines (OPV) Sales by Application (2016-2021) & (M Doses)

Table 107. Latin America Oral Polio Vaccines (OPV) Sales by Application (2022-2027) & (M Doses)

Table 108. Latin America Oral Polio Vaccines (OPV) Revenue by Application (2016-2021) & (US$ Million)

Table 109. Latin America Oral Polio Vaccines (OPV) Revenue by Application (2022-2027) & (US$ Million)

Table 110. Latin America Oral Polio Vaccines (OPV) Sales by Country (2016-2021) & (M Doses)

Table 111. Latin America Oral Polio Vaccines (OPV) Sales by Country (2022-2027) & (M Doses)

Table 112. Latin America Oral Polio Vaccines (OPV) Revenue by Country (2016-2021) & (US$ Million)

Table 113. Latin America Oral Polio Vaccines (OPV) Revenue by Country (2022-2027) & (US$ Million)

Table 114. Middle East and Africa Oral Polio Vaccines (OPV) Sales by Company (2016-2021) & (M Doses)

Table 115. Middle East and Africa Oral Polio Vaccines (OPV) Sales Market Share by Company (2016-2021)

Table 116. Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Company (2016-2021) & (US$ Million)

Table 117. Middle East and Africa Oral Polio Vaccines (OPV) Revenue Market Share by Company (2016-2021)

Table 118. Middle East and Africa Oral Polio Vaccines (OPV) Sales by Application (2016-2021) & (M Doses)

Table 119. Middle East and Africa Oral Polio Vaccines (OPV) Sales by Application (2022-2027) & (M Doses)

Table 120. Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Application (2016-2021) & (US$ Million)

Table 121. Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Application (2022-2027) & (US$ Million)

Table 122. Middle East and Africa Oral Polio Vaccines (OPV) Sales by Application (2016-2021) & (M Doses)

Table 123. Middle East and Africa Oral Polio Vaccines (OPV) Sales by Application (2022-2027) & (M Doses)

Table 124. Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Application (2016-2021) & (US$ Million)

Table 125. Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Application (2022-2027) & (US$ Million)

Table 126. Middle East and Africa Oral Polio Vaccines (OPV) Sales by Country (2016-2021) & (M Doses)

Table 127. Middle East and Africa Oral Polio Vaccines (OPV) Sales by Country (2022-2027) & (M Doses)

Table 128. Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Country (2016-2021) & (US$ Million)

Table 129. Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Country (2022-2027) & (US$ Million)

Table 130. Sanofi Corporation Information

Table 131. Sanofi Description and Overview

Table 132. Sanofi Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (Million US$), Average Selling Price (ASP) (USD/Doses) and Gross Margin (2016-2021)

Table 133. Sanofi Oral Polio Vaccines (OPV) Product and Services

Table 134. Sanofi Oral Polio Vaccines (OPV) SWOT Analysis

Table 135. Sanofi Recent Developments

Table 136. GSK Corporation Information

Table 137. GSK Description and Overview

Table 138. GSK Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (Million US$), Average Selling Price (ASP) (USD/Doses) and Gross Margin (2016-2021)

Table 139. GSK Oral Polio Vaccines (OPV) Product and Services

Table 140. GSK Oral Polio Vaccines (OPV) SWOT Analysis

Table 141. GSK Recent Developments

Table 142. Bibcol Corporation Information

Table 143. Bibcol Description and Overview

Table 144. Bibcol Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (Million US$), Average Selling Price (ASP) (USD/Doses) and Gross Margin (2016-2021)

Table 145. Bibcol Oral Polio Vaccines (OPV) Product and Services

Table 146. Bibcol Oral Polio Vaccines (OPV) SWOT Analysis

Table 147. Bibcol Recent Developments

Table 148. Serum Institute Corporation Information

Table 149. Serum Institute Description and Overview

Table 150. Serum Institute Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (Million US$), Average Selling Price (ASP) (USD/Doses) and Gross Margin (2016-2021)

Table 151. Serum Institute Oral Polio Vaccines (OPV) Product and Services

Table 152. Serum Institute Oral Polio Vaccines (OPV) SWOT Analysis

Table 153. Serum Institute Recent Developments

Table 154. Tiantan Biological Corporation Information

Table 155. Tiantan Biological Description and Overview

Table 156. Tiantan Biological Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (Million US$), Average Selling Price (ASP) (USD/Doses) and Gross Margin (2016-2021)

Table 157. Tiantan Biological Oral Polio Vaccines (OPV) Product and Services

Table 158. Tiantan Biological Oral Polio Vaccines (OPV) SWOT Analysis

Table 159. Tiantan Biological Recent Developments

Table 160. Panacea Biotec Ltd Corporation Information

Table 161. Panacea Biotec Ltd Description and Overview

Table 162. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (Million US$), Average Selling Price (ASP) (USD/Doses) and Gross Margin (2016-2021)

Table 163. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product and Services

Table 164. Panacea Biotec Ltd Oral Polio Vaccines (OPV) SWOT Analysis

Table 165. Panacea Biotec Ltd Recent Developments

Table 166. Bio-Med Corporation Information

Table 167. Bio-Med Description and Overview

Table 168. Bio-Med Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (Million US$), Average Selling Price (ASP) (USD/Doses) and Gross Margin (2016-2021)

Table 169. Bio-Med Oral Polio Vaccines (OPV) Product and Services

Table 170. Bio-Med Oral Polio Vaccines (OPV) SWOT Analysis

Table 171. Bio-Med Recent Developments

Table 172. Halfkin Bio-Pharmaceuticals Corporation Information

Table 173. Halfkin Bio-Pharmaceuticals Description and Overview

Table 174. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (Million US$), Average Selling Price (ASP) (USD/Doses) and Gross Margin (2016-2021)

Table 175. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product and Services

Table 176. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) SWOT Analysis

Table 177. Halfkin Bio-Pharmaceuticals Recent Developments

Table 178. Key Raw Materials Lists

Table 179. Raw Materials Key Suppliers Lists

Table 180. Oral Polio Vaccines (OPV) Distributors List

Table 181. Oral Polio Vaccines (OPV) Customers List

Table 182. Research Programs/Design for This Report

Table 183. Key Data Information from Secondary Sources

Table 184. Key Data Information from Primary Sources

List of Figures

Figure 1. Oral Polio Vaccines (OPV) Product Picture

Figure 2. Global Oral Polio Vaccines (OPV) Sales Market Share by Type in 2020 & 2027

Figure 3. Trivalent OPV Picture

Figure 4. Bivalent OPV Picture

Figure 5. Global Oral Polio Vaccines (OPV) Sales Market Share by Application in 2020 & 2027

Figure 6. Public Use Case

Figure 7. Private Use Case

Figure 8. Oral Polio Vaccines (OPV) Report Years Considered

Figure 9. Global Oral Polio Vaccines (OPV) Revenue, (US$ Million), 2016 VS 2021 VS 2027

Figure 10. Global Oral Polio Vaccines (OPV) Market Size 2016-2027 (US$ Million)

Figure 11. Global Oral Polio Vaccines (OPV) Sales (2016-2021) & (M Doses)

Figure 12. Global Oral Polio Vaccines (OPV) Market Size Market Share by Region: 2020 VS 2027

Figure 13. Global Oral Polio Vaccines (OPV) Sales Market Share by Region (2016-2021)

Figure 14. Global Oral Polio Vaccines (OPV) Sales Market Share by Region in 2020

Figure 15. Global Oral Polio Vaccines (OPV) Revenue Market Share by Region in 2016 VS 2020

Figure 16. Global Oral Polio Vaccines (OPV) Sales Share by Manufacturers In 2020

Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Polio Vaccines (OPV) Sales in 2020

Figure 18. Oral Polio Vaccines (OPV) Revenue Share by Manufacturers In 2020

Figure 19. Oral Polio Vaccines (OPV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020

Figure 20. Global Oral Polio Vaccines (OPV) Revenue Share by Type (2016-2021)

Figure 21. Global Oral Polio Vaccines (OPV) Revenue Growth Rate by Type in 2016 & 2020

Figure 22. Global Oral Polio Vaccines (OPV) Revenue Share by Application (2016-2021)

Figure 23. Global Oral Polio Vaccines (OPV) Revenue Growth Rate by Application in 2016 & 2020

Figure 24. North America Oral Polio Vaccines (OPV) Sales Market Share by Type (2016-2027)

Figure 25. North America Oral Polio Vaccines (OPV) Revenue Market Share by Type (2016-2027)

Figure 26. North America Oral Polio Vaccines (OPV) Sales Market Share by Application (2016-2027)

Figure 27. North America Oral Polio Vaccines (OPV) Revenue Market Share by Application (2016-2027)

Figure 28. North America Oral Polio Vaccines (OPV) Sales Share by Country (2016-2027)

Figure 29. North America Oral Polio Vaccines (OPV) Revenue Share by Country (2016-2027)

Figure 30. U.S. Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 31. Canada Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 32. Europe Oral Polio Vaccines (OPV) Sales Market Share by Type (2016-2027)

Figure 33. Europe Oral Polio Vaccines (OPV) Revenue Market Share by Type (2016-2027)

Figure 34. Europe Oral Polio Vaccines (OPV) Sales Market Share by Application (2016-2027)

Figure 35. Europe Oral Polio Vaccines (OPV) Revenue Market Share by Application (2016-2027)

Figure 36. Europe Oral Polio Vaccines (OPV) Sales Share by Country (2016-2027)

Figure 37. Europe Oral Polio Vaccines (OPV) Revenue Share by Country (2016-2027)

Figure 38. Germany Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 39. France Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 40. U.K. Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 41. Italy Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 42. Russia Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 43. Asia Pacific Oral Polio Vaccines (OPV) Sales Market Share by Type (2016-2027)

Figure 44. Asia Pacific Oral Polio Vaccines (OPV) Revenue Market Share by Type (2016-2027)

Figure 45. Asia Pacific Oral Polio Vaccines (OPV) Sales Market Share by Application (2016-2027)

Figure 46. Asia Pacific Oral Polio Vaccines (OPV) Revenue Market Share by Application (2016-2027)

Figure 47. Asia Pacific Oral Polio Vaccines (OPV) Sales Share by Region (2016-2027)

Figure 48. Asia Pacific Oral Polio Vaccines (OPV) Revenue Share by Region (2016-2027)

Figure 49. China Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 50. Japan Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 51. South Korea Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 52. India Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 53. Australia Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 54. Taiwan Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 55. Indonesia Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 56. Thailand Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 57. Malaysia Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 58. Philippines Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 59. Vietnam Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 60. Latin America Oral Polio Vaccines (OPV) Sales Market Share by Type (2016-2027)

Figure 61. Latin America Oral Polio Vaccines (OPV) Revenue Market Share by Type (2016-2027)

Figure 62. Latin America Oral Polio Vaccines (OPV) Sales Market Share by Application (2016-2027)

Figure 63. Latin America Oral Polio Vaccines (OPV) Revenue Market Share by Application (2016-2027)

Figure 64. Latin America Oral Polio Vaccines (OPV) Sales Share by Country (2016-2027)

Figure 65. Latin America Oral Polio Vaccines (OPV) Revenue Share by Country (2016-2027)

Figure 66. Mexico Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 67. Brazil Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 68. Argentina Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 69. Middle East and Africa Oral Polio Vaccines (OPV) Sales Market Share by Type (2016-2027)

Figure 70. Middle East and Africa Oral Polio Vaccines (OPV) Revenue Market Share by Type (2016-2027)

Figure 71. Middle East and Africa Oral Polio Vaccines (OPV) Sales Market Share by Application (2016-2027)

Figure 72. Middle East and Africa Oral Polio Vaccines (OPV) Revenue Market Share by Application (2016-2027)

Figure 73. Middle East and Africa Oral Polio Vaccines (OPV) Sales Share by Country (2016-2027)

Figure 74. Middle East and Africa Oral Polio Vaccines (OPV) Revenue Share by Country (2016-2027)

Figure 75. Turkey Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 76. Saudi Arabia Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 77. U.A.E Oral Polio Vaccines (OPV) Revenue (2016-2027) & (US$ Million)

Figure 78. Oral Polio Vaccines (OPV) Value Chain

Figure 79. Oral Polio Vaccines (OPV) Production Process

Figure 80. Channels of Distribution

Figure 81. Distributors Profiles

Figure 82. Bottom-up and Top-down Approaches for This Report

Figure 83. Data Triangulation

Figure 84. Key Executives Interviewed

Please fill the form below, to recieve the report sample


+1